The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events: An Individual Participant Data Analysis From 6 Prospective Cohorts
Open accessAbstract
Background—: American College of Cardiology/American Heart Association guidelines for the diagnosis and management of heart failure recommend investigating exacerbating conditions such as thyroid dysfunction, but without specifying the impact of different thyroid-stimulation hormone (TSH) levels. Limited prospective data exist on the association between subclinical thyroid dysfunction and heart failure events. Methods and Results—: We performed a pooled analysis of individual participant data using all available prospective cohorts with thyroid function tests and subsequent follow-up of heart failure events. Individual data on 25 390 participants with 216 248 person-years of follow-up were supplied from 6 prospective cohorts in the United States and Europe. Euthyroidism was defined as TSH of 0.45 to 4.49 mIU/L, subclinical hypothyroidism as TSH of 4.5 to 19.9 mIU/L, and subclinical hyperthyroidism as TSH <0.45 mIU/L, the last two with normal free thyroxine levels. Among 25 390 participants, 2068 (8.1%) had subclinical hypothyroidism and 648 (2.6%) had subclinical hyperthyroidism. In age- and sex-adjusted analyses, risks of heart failure events were increased with both higher and lower TSH levels ( P for quadratic pattern <0.01); the hazard ratio was 1.01 (95% confidence interval, 0.81–1.26) for TSH of 4.5 to 6.9 mIU/L, 1.65 (95% confidence interval, 0.84–3.23) for TSH of 7.0 to 9.9 mIU/L, 1.86 (95% confidence interval, 1.27–2.72) for TSH of 10.0 to 19.9 mIU/L ( P for trend <0.01) and 1.31 (95% confidence interval, 0.88–1.95) for TSH of 0.10 to 0.44 mIU/L and 1.94 (95% confidence interval, 1.01–3.72) for TSH <0.10 mIU/L ( P for trend=0.047). Risks remained similar after adjustment for cardiovascular risk factors. Conclusion—: Risks of heart failure events were increased with both higher and lower TSH levels, particularly for TSH ≥10 and <0.10 mIU/L.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The risk of HF events did not differ after further adjustments for potential confounding risk factors and after the exclusion of patients with preexisting HF or AF [75] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among the 648 participants with SHyper, the HR for HF events was significantly increased during a median follow-up of 10.4 years in ageand sex-adjusted analyses, although a limited number of participants were <50 years.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Data from all the available prospective cohort studies demonstrate that SHyper is associated with an increased risk of total mortality, CHD mortality and incident AF.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, these meta-analyses performed sensitivity analyses excluding participants with missing values of FT 4 and total FT 3 , and used the I 2 statistic to assess heterogeneity across studies.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Three recent meta-analyses provide evidence, based also on IPD data, for treating SHyper with undetectable TSH because of an excess risk of total mortality, CHD mortality, HF, incident AF and fractures among adults with grade 2 SHyper [71,75,108,109] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although these meta-analyses do not show evidence that treatment is effective in improving the risks associated with untreated SHyper, they demonstrate that SHyper is a potentially life-threatening condition.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The risk of HF was much higher in participants with grade 2 SHyper (HR = 1.94; 95% CI: 1.01-3.72)than in those with grade 1 SHyper (HR = 1.31; 95% CI: 0.88-1.95;p for trend across lower TSH categories 0.047).”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
The cited source says what the claim attributes to it.
In the citing paper
“The task force recognized that two recent meta-analyses have provided relevant information on the cardiovascular outcome of SHyper because they included IPD from all the available prospective studies [71,75] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
The cited source says what the claim attributes to it.
In the citing paper
“The risks of CHD mortality and AF are greater among adults with grade 2 SHyper [71,75] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
The cited source says what the claim attributes to it.
In the citing paper
“They assessed baseline cardiovascular risk factors, pre-existing cardiovascular disease (CVD) and thyroid-altering medication use, and stratified the analysis by age, sex, race and TSH categories [71,75] .”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
The cited source says what the claim attributes to it.
In the citing paper
“Although these meta-analyses do not show evidence that treatment is effective in improving the risks associated with untreated SHyper, they demonstrate that SHyper is a potentially life-threatening condition.”
From The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism (2015) · cites this paper as [75]
In the citing paper
“Recent individual patient meta-analysis by the Thyroid Studies Collaboration8,9,10,11 did not find higher risk of CVD and all-cause mortality among adults with subclinical hypothyroidism compared with those with euthyroidism”
From Association of subclinical hypothyroidism and cardiovascular disease with mortality (2020) · cites this paper as [9]
In the citing paper
“The most recent data indicate that SH subjects appear to be at particular risk for the development of heart failure (381,388,392), especially older subjects (381,392) and those with lower TSH levels (392).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [392]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Hollowell, J. G., Staehling, N. W., Flanders, W. D., Hannon, W. H., Gunter, E. W., Spencer, C. A., & Braverman, L. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.489 · Cited by 4,279
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,739
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Redfield, M. M., Jacobsen, S. J., Burnett, J. C. J., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 2,989
Investigating and dealing with publication and other biases in meta-analysis
Sterne, J. A. C., Egger, M., & Smith, G. D. (2001) · BMJ · doi:10.1136/bmj.323.7304.101 · Cited by 2,225
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Trends in Heart Failure Incidence and Survival in a Community-Based Population
Roger, V. L. (2004) · JAMA · doi:10.1001/jama.292.3.344 · Cited by 1,616
Lifetime Risk for Developing Congestive Heart Failure
Lloyd‐Jones, D. M., Larson, M. G., Leip, E. P., Beiser, A., D’Agostino, R. B., Kannel, W. B., Murabito, J. M., Vasan, R. S., Benjamin, E. J., & Levy, D. A. (2002) · Circulation · doi:10.1161/01.cir.0000039105.49749.6f · Cited by 1,615
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
Jessup, M. L., Abraham, W. T., Casey, D. E., Feldman, A. M., Francis, G. S., Ganiats, T. G., Konstam, M. A., MANCINI, D. M., Rahko, P. S., Silver, M. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192064 · Cited by 1,420
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1210/jcem.87.2.8182 · DOI · Paper page
Cited by
Sorted by citations
Items 401–500 of 517
Thyroid disease in peri‑ and postmenopause period (literature review)
Zaidieva, Y. Z., Glazkova, A. V., & Kruchinina, E. V. (2020) · Medical alphabet · doi:10.33667/2078-5631-2019-4-33(408)-48-53 · Cited by 1
Hyperthyreose – Fokus Immunthyreopathie Basedow
Theiler‐Schwetz, V., Trummer, C., & Pilz, S. (2020) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-020-00112-x · Cited by 1
Pearce, S. H. S. (2022) · doi:10.1093/med/9780198870197.003.0057 · Cited by 1
Tong, R., Wu, T., & Chen, J. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230501151924 · Cited by 1
Optimizing TSH Testing: Minimizing Overdiagnosis and Unnecessary Interventions
Bayona, K. L. P. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1005108 · Cited by 2
Chung, H.-K. (2024) · Korean Journal of Medicine · doi:10.3904/kjm.2024.99.3.127 · Cited by 1
Evaluation of the risk of hypothyroidism and its clinical manifestations using the Zulewski scale
Ferreira‐Hermosillo, A., Toledo, J. O., & Cordoba, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1416663 · Cited by 1
Yoo, M. H., Kim, H. J., Park, S., Park, S. J., Park, H. K., Byun, D. W., & Suh, K. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae212 · Cited by 2
Yadav, V., Jha, R. K., Pawar, A., Singhai, A., Agarwal, R., Meena, M., Runwal, G., Chouhan, B., Yadav, A., & Razdan, M. (2025) · Cureus · doi:10.7759/cureus.88288 · Cited by 1
Ren, J., Wang, Y.-G., Zheng, J., Wang, W., & Tang, Y. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.133794 · Cited by 1
Treatment options of subclinical hyperthyroidism and cardiovascular risk
Kyrilli, A., Lytrivi, M., Lassen, P. B., & Corvilain, B. (2018) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2018.01.008 · Cited by 2
Diastolic and Systolic Dysfunction of the Heart and Thyroid Hormone Abnormalities
Tang, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_5 · Cited by 1
Sazonоva, A. G., Mokhort, T. V., Karlovich, N., Snapkov, V. S., Valovik, O. E., & Ilinchik, O. V. (2020) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.16.1.2020.199122 · Cited by 1
Echocardiographic Evaluation In Mild Subclinical Hypothyroidism: Results from the TRUST Trial
Biondi, B. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.214-217 · Cited by 1
Cetin, E. H., Çetin, M. S., Könte, H. C., Ocak, K., Yaman, N. M., Hepşen, S., Özeke, Ö., Temizhan, A., Topaloğlu, S., & Aras, D. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0425 · Cited by 2
Hassan, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_11 · Cited by 1
Chillarón, J. J., Climent, E., Llauradó, G., Ballesta, S., & Roux, J. A. F. (2022) · FMC - Formación Médica Continuada en Atención Primaria · doi:10.1016/j.fmc.2021.04.008 · Cited by 1
Lin, H., & Wang, T. (2017) · Europe PMC (PubMed Central) · doi:10.6515/acs20170626b · Cited by 1
Kocełak, P., Mossakowska, M., Puzianowska‐Kuźnicka, M., Sworczak, K., Wyszomirski, A., Handzlik‐Orlik, G., Stefański, A., Zdrojewski, T. R., & Chudek, J. T. (2021) · Research Square · doi:10.21203/rs.3.rs-735681/v1 · Cited by 1
Triggiani, V., & Lisco, G. (2021) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530321666211215144023 · Cited by 1
Self-citationPearce, E. N. (2015) · Clinical Thyroidology · doi:10.1089/ct.2015;27.177-179
Thyroid Dysfunction in Patients With Myocardial Infarction With Normal Coronary Arteries
Agewall, S., & Tornvall, P. (2013) · Angiology · doi:10.1177/0003319712471071
Guan, F., Zhao, H., Jiao, B., Liu, S., Sa, R., Hou, S., Lin, Q., Wang, Q., & Lin, C. (2015) · Annals of Nuclear Medicine · doi:10.1007/s12149-015-1046-7
Subclinical Thyroid Disease Increases Risk for HF Events
Masoudi, F. A., Msph, Facc, & Faha (2012) · Journal watch · doi:10.1056/jc201209190000003
Pasqualetti, G., Calsolaro, V., & Monzani, F. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.04.11
Original / Síndrome metabólico Hipotiroidismo subclínico y riesgo cardiovascular
Antonia, M., Rubio, L., López, P. J. T., Montes, J. A. R., Albero, J. S., & López, P. B. (2015)
Winzeler, B. F., Christ‐Crain, M., Müller, B., & Meier, C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.04162-3
Muneer, A. R., & Kalyagin, A. N. (2013) · CyberLeninK (CyberLeninka)
When to Treat a Suppressed TSH
Ward, L. S., & Sgarbi, J. A. (2014) · The Endocrine Society eBooks · doi:10.1210/mtp3.9781936704835.ch55
Guías de práctica clínica para el tratamiento del hipotiroidismo
Brenta, G., Vaisman, M., Sgarbi, J. A., de Andrada, N. C., Bravo, P. P., Orlandi, A. M., & Graf, H. (2013)
Thyroid Disorders in the Elderly
Tabatabaie, V., & Surks, M. I. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.95832-x
Thyroid Disorders in Climacteric Women
Brona, A., Milewicz, A., Kuliczkowska-Płaksej, J., & Bolanowski, M. (2018) · ISGE series · doi:10.1007/978-3-319-63540-8_8
Subklinik Hipotiroidi Nedir? Tedavi Edilmeli midir?
Gül, Ö. Ö., Cander, S., & Ersoy, C. (2018) · Uludağ Üniversitesi Tıp Fakültesi Dergisi · doi:10.32708/uutfd.435351 · Cited by 1
Biondi, B., & Kahaly, G. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_26
Biondi, B., & Kahaly, G. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_21
Four Potentially Practice-Changing Articles From 2018
Patterson, C. J. (2019) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.01.138
Thyroid Status and Outcomes in Kidney Disease
Rhee, C. M., Brent, G. A., & Kalantar‐Zadeh, K. (2019) · Springer eBooks · doi:10.1007/978-3-319-97765-2_8
Thyroid Hormone Abnormalities in Myocardial Infarction
Varvarousis, D., Chryssanthopoulos, S., Polytarchou, K., & Cokkinos, D. V. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_21
Modalities of Thyroid Hormone Administration and Correlates Between Blood and Tissue Levels
Celi, F. S. (2020) · Springer eBooks · doi:10.1007/978-3-030-36871-5_26
Osteoprotegerin levels in children with subclinical hypothyroidism
Giannakopoulos, A., Katsantoni, E., Kritikou, D., & Chrysis, D. (2020) · Acta Paediatrica · doi:10.1111/apa.15291
Biondi, B. (2020) · Clinical Thyroidology · doi:10.1089/ct.2020;32.471-473
Hypothyroidism and heart failure.
Kravchenko, A. Y., Budnevskiy, А. V., & Kuzina, M. S. (2018) · Clinical Medicine (Russian Journal) · doi:10.18821/0023-2149-2018-96-5-397-400
Latente Hypothyreose - (k)ein Problem?
Lichtenauer, U. D., & Reincke, M. (2020) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-020-4370-3
ASSOCIATION OF SUBCLINICAL HYPOTHYROIDISM WITH METABOLIC SYNDROME: A CROSS-SECTIONAL STUDY
Jha, R. K., Jha, S. N., Jha, V., Jha, K. K., & Jana, D. (2020) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/8624190
Challenges in Defining and Studying Subclinical Hypothyroidism in Older Adults
Modarressi, T. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.08.024
К.В., В., Reznichenko, O., Vlasenko, O., Gridnieva, S. V., & Kratenko, H. (2020) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2020-40-13
Thyroid Dysfunction and Metabolism: Diagnosis and Follow-Up
Luzi, L., Massarini, S., Terruzzi, I., Ferrulli, A., & Cusini, C. (2021) · Springer eBooks · doi:10.1007/978-3-030-80267-7_11
Risk of disorders of nonspecific resistance due to long-term exposure to radiation in small doses.
Pivina, L. M., Semenova, Y. M., Белихина, Т. И., Manatova, A., Dyussupov, A. A., & Aukenov, N. (2017) · Ġylym men densaulyķ saķtau.
Chaturvedi, A., Khoury, F. R., Vashistha, K., PATEL, K., Mareda, P., Veasey, T. M., Link, C., & Raina, A. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.09.014
Brenta, G., & Sgarbi, J. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-72102-6_24
Dominguez, L. J., & Barbagallo, M. (2022) · Wiley eBooks · doi:10.1002/9781119484288.ch83
Wémeau, J.-L. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77583-3.00016-2
Hassan, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-25871-3_10
Editors, T. (2013) · Circulation · doi:10.1161/circulationaha.113.003137
Proust-Lemoine, E., & Wémeau, J.-L. (2018) · EMC - AKOS - Trattato di Medicina · doi:10.1016/s1634-7358(18)91702-x
Proust-Lemoine, E., & Wémeau, J.-L. (2018) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(18)91423-6
Low-grade systemic inflammation in subclinical hypothyroidism
Vudu, S., & Krishna, G. D. (2022) · The Moldovan Medical Journal · doi:10.52418/moldovan-med-j.65-1.22.09
Avicultura: O bem-estar na criação de frangos para corte na atualidade
Filho, A. B. D. N., da Silva, M. D. A., Campos, L. B., & de Alencar, T. D. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.30
Monkeypox e sua prevalência no Brasil
Galvão, I. L. S., Lopes, G. D. S., & Silva, M. J. D. M. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.13
Hipotireoitismo e sistema cardiovascular – Revisão de literatura
Lemos, M. C., Centolanza, D. S., Dutra, M. D. O., & Rodrigues, N. C. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.04
Andrade, V. K. C., de Oliveira, N. C. D. S., & BARBOSA, J. B. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.23
Lemos, L. B., Quadros, P. D. M., & da Costa, L. F. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.15
de Souza, C. Ê. S. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.29
A importância da monitoria acadêmica para a formação profissional: Um relato de experiência
Soares, F. S. M. D. C., Dutra, M. D. O., Lopes, F. L. G., & Pavanelo, V. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.08
Hipertireoidismo e sistema cardiovascular – Revisão de literatura
Centolanza, D. S., Dutra, M. D. O., Lemos, M. C., & Rodrigues, N. C. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.03
da Silva, J. C. S., Vieira, H. R. L., Pereira, E. S. D. S., Rezende, I. R. L., & Barbosa, J. B. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.22
A relevância do estudo prático da anatomia humana para prática médica – Uma revisão de literatura
Dutra, M. D. O., Soares, F. S. M. D. C., Lopes, F. L. G., Veras, D. D. S., & Pavanelo, V. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.01
Relato de caso: Cirurgia de maxilectomia rosto central bilateral em cão
Monteiro, K. M. D. S., Gomes, F. A. P., & de Souza, S. S. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.27
Sífilis secundária simulando artrite reumatoide: Um relato de caso
Soares, L. A. S. D. P., de Lima, D. S. N., & Cavalcante, A. D. S. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.09
Manifestações neurológicas da malária cerebral
da Costa, L. F., & Lemos, L. B. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.16
Hiperplasia fibrosa inflamatória: Revisão de literatura
Vieira, H. R. L., da Silva, J. C. S., Dornelis, L. R., & Barbosa, J. B. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.21
Efeitos do hormônio tireoidiano na contratilidade e hemodinâmica cardíaca – Revisão de literatura
Dutra, M. D. O., Lemos, M. C., Centolanza, D. S., & Rodrigues, N. C. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.05
A importância da ultrassonografia na rotina clínica veterinária de pequenos animais
Gomes, F. A. P., Monteiro, K. M. D. S., & de Souza, S. S. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.32
VII ConCIFA - Congresso Científico FAMETRO: Ciência Inclusiva - 2022
(2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7
Manejo cirúrgico de tórus mandibular bilateral com finalidade protética: Relato de caso
Sabóia, S. S. C., da Silva, G. A., da Rocha, P. L. C., de Souza, G. C., & Carvalho, H. M. P. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.25
Os efeitos terapeuticos da dança na doença de Parkinson: Uma revisão integrativa
de Almeida, L. S., & Magalhães, J. R. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.17
Do uso terapêutico ao uso indiscriminado de metilfenidato por estudantes
Mendonça, L. M., Lima, D. C. D. C., Maues, L. M. L., de Souza, K. C., & Nery, I. V. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.02
Silva, L. D. S., & Lopes, G. D. S. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.11
Dentistas como agentes de saúde e educação na comunidade
Dias, G. M., Mendonça, L. F. A., de Albuquerque, R. V. F., Melo, E. D. C., Pereira, A. D. L., Cunha, I. D. O., Benedetto, M. D., Martinho, R. L. D. M., de Oliveira, N. C. D. S., de Figueiredo, S. C. G., et al. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.24
Fisiopatologia da síndrome cardiorrenal em cães: Revisão de literatura
Silva, B. T. P., Simas, C. M., & Campos, L. B. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.31
Cunicultura visando no bem-estar de coelhos criados em gaiolas
de Sena, A. L., dos Santos, A. E. P., Waked, A., Pinheiro, A. J. C., Viana, B. G. P., Melo, E. M., da Cunha, E. V., dos Anjos, L. T., de Souza, L. C., Bindá, L. R. M., et al. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.28
O uso de energia solar pelo exército brasileiro nos pelotões especiais de fronteira da Amazônia
Trovão, J. D. A. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.34
Subclinical hypothyroidism: Let the evidence be your guide
LeFevre, N. M. (2023) · The Journal of Family Practice · doi:10.12788/jfp.0593 · Cited by 3
Ansiedade do adolescente em época de pandemia
Gama, D., & Clementino, J. (2023) · Editora Poisson eBooks · doi:10.36229/978-65-5866-261-7.cap.36
KAPLAN, A. K., & Sezgin, Y. (2023) · Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi · doi:10.37989/gumussagbil.1324955
Thyroid dysfunction in the ageing patient
Bilookyi, O. V., Vasiuk, V. L., & Shupik, O. A. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.20.2.2024.1376
Shen, Y., Xiong, D., Zhou, H., Wang, X., Zhao, T., Li, X., Sun, M., Yu, S., Huang, X., Cao, S., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4388105/v1
Monika, K., Banait, S., Salunkhe, P., & Jain, J. (2021) · Journal of Datta Meghe Institute of Medical Sciences University · doi:10.4103/jdmimsu.jdmimsu_260_20
Yazar, A., & Hakgör, A. (2024) · Dicle Medical Journal / Dicle Tip Dergisi · doi:10.5798/dicletip.1501320
Gridneva, Y. Y., Chesnikova, A. I., Сафроненко, В. А., & Voronova, A. (2024) · South Russian Journal of Therapeutic Practice · doi:10.21886/2712-8156-2024-5-2-48-57
Bushra, H., & Rashid, M. (2024) · Avicenna Journal of Medicine · doi:10.1055/s-0044-1788040
Treatment of Subclinical Hypothyroidism Slightly Reduces Risk of Cardiovascular Events
Jin, A., & Hussain, I. (2024) · Clinical Thyroidology · doi:10.1089/ct.2024;36.359-361
Ito, M., & Akamizu, T. (2024) · Clinical Thyroidology · doi:10.1089/ct.2024;36.396-398
Ceylan, Ş. (2024) · Medical Science and Discovery · doi:10.36472/msd.v11i12.1237
Ursem, S. R., Noordam, R., van den Berg, J. M., Boelen, A., Elders, P. J. M., den Elzen, W. P. J., & Heijboer, A. C. (2025) · Thyroid · doi:10.1177/10507256261449444
Zhao, L., Mu, R., Zhang, X., Wang, S., Zhao, M., & Shang, H. (2025) · Research Square · doi:10.21203/rs.3.rs-6780346/v1
Svensson, J., Ohlsson, C., Karlsson, M. K., Tivesten, Å., Herlitz, H., Lorentzon, M., Lewerin, C., & Mellström, D. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf121
Multigenerational thyroid hormone resistance due to THRβ mutation
Kopanos, S., & Feldkamp, J. (2025) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaf338
Hassan, A. A., Shehawy, E. S. E., Esmail, M. S., Hossam-Eldin, G. E., Allah, R. M. F., Abozeid, H. E., Mohammed, D. S., Yassien, M., Ahmed, S. A., Salama, D. M., et al. (2025) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-025-01619-6
Metadata
- Authors
- Gencer, B., Collet, T.-H., Virgini, V., Bauer, D. C., Gussekloo, J., Cappola, A. R., Nanchen, D., den Elzen, W. P. J., Balmer, P., Luben, R. N., Iacoviello, M., Triggiani, V., Cornuz, J., Newman, A. B., Khaw, K.-T., Jukema, J. W., Westendorp, R. G. J., Vittinghoff, E., Aujesky, D., & Rodondi, N.
- Affiliations
- From the Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland (B.G., T.-H.C., D.N., P.B., J.C.); Department of General Internal Medicine, Bern University Hospital, Bern, Switzerland (V.V., D.A., N.R.); Departments of Epidemiology and Biostatistics (D.C.B., E.V.) and Medicine (D.C.B.), University of California San Francisco; Departments of Public Health and Primary Care (J.G., W.P.J.d.E.), Cardiology (J.W.J.), and Gerontology and Geriatrics (R.G.J.W.),...
- University of Pittsburgh (US)
- ORCID
- Venue
- Circulation
- Published
- 2012-08-28
- Volume
- 126
- Issue
- 9
- Pages
- 1040-1049
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC3884576
- OpenAlex
- W2000333200
- Cited by
- 517
- References
- 41
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 36 · 2023: 61 · 2022: 34 · 2021: 48 · 2020: 44 · 2019: 39 · 2018: 37 · 2017: 30 · 2016: 26 · 2015: 39 · 2014: 31 · 2013: 32 · 2012: 7
- FWCI
- 27.97
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (acceptedVersion, other-oa)
- Leiden Repository (Leiden University) (submittedVersion)
- IRIS (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- BORIS (University Library Bern) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion, other-oa)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- National Science Foundation
- American Heart Association
- Bristol-Myers Squibb
- University of Pittsburgh (P30-AG024827)
- Cancer Research UK
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SPUM 33CM30-124 112, 15103, 138267, 20098, 124112, 320030)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (050.060.810, 05040202)
- National Institutes of Health (N01-AG-6-2103, n01hc085082-026, n01hc085081-021, n01ag062101-007, n01hc045133-001, n01hc085079-024, n01hc015103-009, n01hc085084-005, n01ag062103-006, n01hc085085-011, n01hc085083-027, n01hc085080-026, N01‐AG‐6‐2106, n01ag062106-007, n01hc085086-022, N01-AG-6-2101, n01hc075150-004, n01hc035129-010, n01hc055222-001, N01HC85086, AG-027058, AG 20098, N01HC85079, HL-075366, AG-023629, N01-HC-75150, N01HC-35129, N01HC-15103, N01-HC-45133, HL080295)
- Medical Research Council
- National Institute on Aging (N01‐AG‐6–2101, R01AG028050, R56AG023629, R01AG032317, R01AG020098, R01-AG-15928, R01 AG20098, AG023629, AG027058, N01AG62106, R01AG023629, R01AG015928, N01-AG-62103, R01AG027058, AG-032317, P30AG024827)
- National Heart, Lung, and Blood Institute (N01-HC-85081, N01HC85085, N01 HC085086, AG-023629, N01HC-85083, AG-027058, R01-NR012459, N01HC15103, N01 HC085079, N01HC85082, N01HC‐75150, N01 HC85086, AG-20098, N01 HC035129, HL-075366, N01HC85080, N01AG62101, N01 HC015103, N01HC80007, N01 HC55222, R01HL075366, N01‐HC‐45133, N01AG62106, U01HL080295, N01 HC055222, R01 HL, N01AG62103, AG-15928, HL080295, N01 HC075150, N01 HC045133, N01-HC85079, N01-HC85084, N01HC35129)
- National Institute of Nursing Research (N01-AG-6–2101, N01-AG-6-2103, N01-AG-6–2106, NR012459, R01NR012459)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (K24AR051895)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- subclinical thyroid dysfunction, heart failure, thyroid-stimulating hormone, subclinical hypothyroidism, subclinical hyperthyroidism, TSH levels, heart failure risk, euthyroidism, free thyroxine, cardiovascular risk factors, individual patient data meta-analysis, prospective cohort, thyroid function tests, heart failure exacerbation, heart failure hospitalization, heart failure mortality, heart failure readmission
- MeSH terms
- Adult, Aged, Aged, 80 and over, Female, Follow-Up Studies, Heart Failure, Humans, Hypothyroidism, Male, Middle Aged, Prospective Studies, Risk, Risk Factors, Sensitivity and Specificity, Thyrotropin, Thyroxine, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
